Y

Yili Chuanning Biotechnology Co Ltd
SZSE:301301

Watchlist Manager
Yili Chuanning Biotechnology Co Ltd
SZSE:301301
Watchlist
Price: 14.14 CNY -3.81% Market Closed
Market Cap: 31.4B CNY
Have any thoughts about
Yili Chuanning Biotechnology Co Ltd?
Write Note

Yili Chuanning Biotechnology Co Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Yili Chuanning Biotechnology Co Ltd
Income from Continuing Operations Peer Comparison

Comparables:
6160
603392
002252
300122
300896

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Y
Yili Chuanning Biotechnology Co Ltd
SZSE:301301
Income from Continuing Operations
ÂĄ940.6m
CAGR 3-Years
60%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Income from Continuing Operations
-ÂĄ6.7B
CAGR 3-Years
16%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Income from Continuing Operations
ÂĄ1.2B
CAGR 3-Years
22%
CAGR 5-Years
34%
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Income from Continuing Operations
ÂĄ1.8B
CAGR 3-Years
5%
CAGR 5-Years
N/A
CAGR 10-Years
23%
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Income from Continuing Operations
ÂĄ6B
CAGR 3-Years
-6%
CAGR 5-Years
26%
CAGR 10-Years
48%
Imeik Technology Development Co Ltd
SZSE:300896
Income from Continuing Operations
ÂĄ1.9B
CAGR 3-Years
62%
CAGR 5-Years
74%
CAGR 10-Years
N/A

See Also

What is Yili Chuanning Biotechnology Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
940.6m CNY

Based on the financial report for Dec 31, 2023, Yili Chuanning Biotechnology Co Ltd's Income from Continuing Operations amounts to 940.6m CNY.

What is Yili Chuanning Biotechnology Co Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 3Y
60%

Over the last year, the Income from Continuing Operations growth was 129%. The average annual Income from Continuing Operations growth rates for Yili Chuanning Biotechnology Co Ltd have been 60% over the past three years .

Back to Top